BioCatalystWatch
CYTKWorkspace / CYTK / OverviewCompany library
Price
Market cap
Next catalystQ4 2026 — complete Cohort 1 enrollmentulacamten — AMBER-HFpEF · Enrollment completionCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

MYQORZO (aficamten)

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

MYQORZO (aficamten)

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ulacamten

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

MYQORZO (aficamten)

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

ulacamten

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

MYQORZO (aficamten)

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

MYQORZO (aficamten)

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
MYQORZO (aficamten)

Small molecule

Cardiac myosin

Upcoming / outlook

ulacamten

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved

Approved / commercial

MYQORZO (aficamten)

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved

Small molecule

Cardiac myosin

PreINDP1P2P3FilingApproved

Fast skeletal muscle troponin

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CYTK PR & News

PR & News

CYTK SEC archive